NICE Stock Analysis: Nice | NASDAQ
Software - Application | NASDAQ, USA | Market Cap: 6.377m USD | 12M Return: -20.3% | US6536561086 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 51.3M
EPS Trend: 90.7%
Qual. Beats: -1
Rev. Trend: 99.2%
Qual. Beats: 3
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Seasonality 11.6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
NICE Ltd. is an Israel-based software company listed on NASDAQ that provides AI-powered cloud platforms across two main segments: Customer Engagement and Financial Crime and Compliance. The Customer Engagement segment is built around its CXone Mpower platform, which helps organizations automate service operations, deploy AI-assisted workforce tools, and unify enterprise knowledge and customer experience workflows. The Financial Crime and Compliance segment delivers embedded-AI solutions for anti-money laundering (AML), fraud prevention, know-your-customer (KYC) processes, and real-time capital markets compliance, with product lines such as NiCE Actimize, X-Sight, and Xceed targeted at institutions of varying sizes.
In addition to its core financial services offerings, the company provides NICE Evidencentral, a digital evidence management platform used in the criminal justice system, and runs NiCE Labs as an internal innovation initiative focused on customer experience technologies. Founded in 1986 and headquartered in Raanana, Israel, NICE operates globally across the United States, Europe, the Middle East, Africa, and Asia Pacific. It is classified within the GICS Information Technology sector and Application Software sub-industry, competing in the enterprise software and regtech/fintech space where recurring SaaS revenue and regulatory demand for compliance tools are key industry characteristics.
- CXone Mpower cloud ARR growth accelerates recurring mix
- Financial Crime and Compliance demand rises on fraud and AML spending
- Competition from Verint and CCaaS peers pressures pricing and margins
| Net Income: 426.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.12 > 0.02 and ΔFCF/TA -0.60 > 1.0 |
| NWC/Revenue: 11.80% < 20% (prev 40.62%; Δ -28.82% < -1%) |
| CFO/TA 0.13 > 3% & CFO 674.2m > Net Income 426.8m |
| Net Debt (-270.3m) to EBITDA (856.4m): -0.32 < 3 |
| Current Ratio: 1.33 > 1.5 & < 3 |
| Outstanding Shares: last quarter (59.4m) vs 12m ago -6.04% < -2% |
| Gross Margin: 65.11% > 18% (prev 67.03%; Δ -1.92% > 0.5%) |
| Asset Turnover: 59.07% > 50% (prev 53.46%; Δ 5.61% > 0%) |
| Interest Coverage Ratio: 1.01k > 6 (EBIT TTM 620.3m / Interest Expense TTM 612k) |
| A: 0.07 (Total Current Assets 1.47b - Total Current Liabilities 1.10b) / Total Assets 5.12b |
| B: 0.65 (Retained Earnings 3.31b / Total Assets 5.12b) |
| C: 0.12 (EBIT TTM 620.3m / Avg Total Assets 5.22b) |
| D: 2.81 (Book Value of Equity 3.78b / Total Liabilities 1.34b) |
| Altman-Z'' = 6.33 = AAA |
| DSRI: 1.13 (Receivables 836.6m/681.0m, Revenue 3.08b/2.84b) |
| GMI: 1.03 (GM 67.03% / 65.11%) |
| AQI: 1.39 (AQ_t 0.66 / AQ_t-1 0.47) |
| SGI: 1.09 (Revenue 3.08b / 2.84b) |
| TATA: -0.05 (NI 426.8m - CFO 674.2m) / TA 5.12b) |
| Beneish M = -2.60 (Cap -4..+1) = A |
As of August 31, 2026, the stock is trading at USD 108.84 with a total of 524,754 shares traded. Over the past week, the price has changed by +8.57%, over one month by +10.07%, over three months by +9.44% and over the past year by -20.27%.
Current recommended Stop Loss: 101.20 (which is 7% or 1.9 ATR below the current price).
Nice has received a consensus analysts rating of 4.33. Therefore, it is recommended to buy NICE.
- StrongBuy: 10
- Buy: 4
- Hold: 4
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 125.9 | 15.6% |
P/E Trailing = 15.8421
P/E Forward = 9.4073
P/S = 2.0777
P/B = 1.6286
P/EG = 0.7841
Revenue TTM = 3.08b USD
EBIT TTM = 620.3m USD
EBITDA TTM = 856.4m USD
Long Term Debt = 74.2m USD (estimated: total debt 88.2m - short term 14.0m)
Short Term Debt = 14.0m USD (from shortTermDebt, last quarter)
Debt = 88.2m USD (from shortLongTermDebtTotal, last quarter) (leases 88.2m already included)
Net Debt = -270.3m USD (calculated: Debt 88.2m - CCE 358.5m)
Enterprise Value = 6.11b USD (6.38b + Debt 88.2m - CCE 358.5m)
Interest Coverage Ratio = 1.01k (Ebit TTM 620.3m / Interest Expense TTM 612k)
EV/FCF = 10.07x (Enterprise Value 6.11b / FCF TTM 606.2m)
FCF Yield = 9.93% (FCF TTM 606.2m / Enterprise Value 6.11b)
FCF Margin = 19.68% (FCF TTM 606.2m / Revenue TTM 3.08b)
Net Margin = 13.85% (Net Income TTM 426.8m / Revenue TTM 3.08b)
Gross Margin = 65.11% ((Revenue TTM 3.08b - Cost of Revenue TTM 1.07b) / Revenue TTM)
Gross Margin QoQ = 64.04% (prev 64.38%)
Tobins Q-Ratio = 1.19 (Enterprise Value 6.11b / Total Assets 5.12b)
Interest Expense / Debt = 0.69% (Interest Expense 612k / Debt 88.2m)
Taxrate = 31.14% (193.0m / 619.7m)
NOPAT = 427.2m (EBIT 620.3m * (1 - 31.14%))
Current Ratio = 1.33 (Total Current Assets 1.47b / Total Current Liabilities 1.10b)
Debt / Equity = 0.02 (Debt 88.2m / totalStockholderEquity, last quarter 3.78b)
Debt / EBITDA = -0.32 (Net Debt -270.3m / EBITDA 856.4m)
Debt / FCF = -0.45 (Net Debt -270.3m / FCF TTM 606.2m)
Total Stockholder Equity = 3.80b (last 4 quarters mean from totalStockholderEquity)
RoA = 8.18% (Net Income 426.8m / Total Assets 5.12b)
RoE = 11.24% (Net Income TTM 426.8m / Total Stockholder Equity 3.80b)
RoCE = 16.02% (EBIT 620.3m / Capital Employed (Equity 3.80b + L.T.Debt 74.2m))
RoIC = 11.02% (NOPAT 427.2m / Invested Capital 3.88b)
WACC = 8.97% (E(6.38b)/V(6.47b) * Re(9.09%) + D(88.2m)/V(6.47b) * Rd(0.69%) * (1-Tc(0.31)))
Discount Rate = 9.09% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -96.86 | Cagr: -4.92%
[DCF] Terminal Value 72.02% ; FCFF base≈627.8m ; Y1≈587.2m ; Y5≈539.7m
[DCF] Fair Price = 136.4 (EV 7.72b - Net Debt -270.3m = Equity 7.99b / Shares 58.6m; r=8.97% [WACC]; 5y FCF grow -8.16% → 2.50% )
EPS Correlation: 90.65 | EPS CAGR: 12.28% | SUE: -2.84 | # QB: -1
Revenue Correlation: 99.19 | Revenue CAGR: 10.79% | SUE: 4.0 | # QB: 3
EPS current Quarter (2026-09-30): EPS=2.78 | Chg30d=-0.55% | Revisions=-31% | Analysts=14
EPS current Year (2026-12-31): EPS=11.17 | Chg30d=+0.74% | Revisions=+80% | GrowthEPS=-9.2% | GrowthRev=+8.0%
EPS next Year (2027-12-31): EPS=12.66 | Chg30d=+0.17% | Revisions=+50% | GrowthEPS=+13.3% | GrowthRev=+9.1%
[Analyst] Revisions Ratio: +42% (up=24, down=9)